患 COVID-19 或流感住院儿童的短期和长期疗效:AUTCOV 研究结果

Christine Wagenlechner, Ralph Wendt, Berthold Reichardt, Michael Mildner, Julia Mascherbauer, Clemens Aigner, Johann Auer, Hendrik Jan Ankersmit, Alexandra Graf
{"title":"患 COVID-19 或流感住院儿童的短期和长期疗效:AUTCOV 研究结果","authors":"Christine Wagenlechner, Ralph Wendt, Berthold Reichardt, Michael Mildner, Julia Mascherbauer, Clemens Aigner, Johann Auer, Hendrik Jan Ankersmit, Alexandra Graf","doi":"10.1101/2024.08.28.24312702","DOIUrl":null,"url":null,"abstract":"Background:\nRecent literature gives different results on morbidity and mortality after COVID-19 as compared to Influenza hospitalized children and results of large, population based studies are scant. In this population-based study in Austria, we evaluated and compared the short- and long-term outcomes after COVID-19 or Influenza hospitalization and associations with their baseline drug profile.\nMethods:\nIndividual data were provided on children ≤ 18 years hospitalized with COVID-19 in the years 2020 and 2021 or Influenza in 2016 to 2021 as well as on age-, sex- and region-matched controls from the Austrian Health Insurance Funds. The primary outcome was time to hospital discharge. Secondary outcomes were in-hospital death, all-cause mortality and readmission to hospital due to any reason. The median follow-up time was 430 days (IQR: 245-552) in the COVID-19 and 1221 days (IQR: 881-1599) in the Influenza group. Results:\n1063 children were hospitalized due to COVID-19 and 2781 children due to Influenza in the study period. Children hospitalized due to COVID-19 or Influenza were more likely to have a larger disease burden as compared to the general population. Influenza hospitalized patients were observed to be generally younger and a larger percentage of polypharmacy than those with COVID-19. No significant difference in the time to hospital discharge was found between cohorts (HR: 1.22 [95%-CI: 0.97-1.55], p=0.093). The risk for readmission was significantly higher for Influenza (HR: 1.23 [95%-CI: 1.03-1.47], p=0.021). In-hospital mortality (0.94% vs. 0.22%, p=0.004) and long-term mortality (p=0.009) was significantly larger in COVID-19 patients. One-year mortality after hospitalization was estimated with 1.13% (CI: 0.49-1.77) in the COVID and 0.32% (CI: 0.11-0.53) in the Influenza group. Conclusion:\nA general picture of COVID-19 being a milder disease compared to Influenza may not be drawn. No significant difference for time to hospital discharge was observed between cohorts but the risk of readmission was significantly larger in the Influenza group. Death rates of COVID-19 hospitalized children seem to be higher, however, the low number of severe events may limit the findings.","PeriodicalId":501276,"journal":{"name":"medRxiv - Public and Global Health","volume":"35 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Short- and Long-term Outcomes of children hospitalized with COVID-19 or Influenza: results of the AUTCOV study\",\"authors\":\"Christine Wagenlechner, Ralph Wendt, Berthold Reichardt, Michael Mildner, Julia Mascherbauer, Clemens Aigner, Johann Auer, Hendrik Jan Ankersmit, Alexandra Graf\",\"doi\":\"10.1101/2024.08.28.24312702\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background:\\nRecent literature gives different results on morbidity and mortality after COVID-19 as compared to Influenza hospitalized children and results of large, population based studies are scant. In this population-based study in Austria, we evaluated and compared the short- and long-term outcomes after COVID-19 or Influenza hospitalization and associations with their baseline drug profile.\\nMethods:\\nIndividual data were provided on children ≤ 18 years hospitalized with COVID-19 in the years 2020 and 2021 or Influenza in 2016 to 2021 as well as on age-, sex- and region-matched controls from the Austrian Health Insurance Funds. The primary outcome was time to hospital discharge. Secondary outcomes were in-hospital death, all-cause mortality and readmission to hospital due to any reason. The median follow-up time was 430 days (IQR: 245-552) in the COVID-19 and 1221 days (IQR: 881-1599) in the Influenza group. Results:\\n1063 children were hospitalized due to COVID-19 and 2781 children due to Influenza in the study period. Children hospitalized due to COVID-19 or Influenza were more likely to have a larger disease burden as compared to the general population. Influenza hospitalized patients were observed to be generally younger and a larger percentage of polypharmacy than those with COVID-19. No significant difference in the time to hospital discharge was found between cohorts (HR: 1.22 [95%-CI: 0.97-1.55], p=0.093). The risk for readmission was significantly higher for Influenza (HR: 1.23 [95%-CI: 1.03-1.47], p=0.021). In-hospital mortality (0.94% vs. 0.22%, p=0.004) and long-term mortality (p=0.009) was significantly larger in COVID-19 patients. One-year mortality after hospitalization was estimated with 1.13% (CI: 0.49-1.77) in the COVID and 0.32% (CI: 0.11-0.53) in the Influenza group. Conclusion:\\nA general picture of COVID-19 being a milder disease compared to Influenza may not be drawn. No significant difference for time to hospital discharge was observed between cohorts but the risk of readmission was significantly larger in the Influenza group. Death rates of COVID-19 hospitalized children seem to be higher, however, the low number of severe events may limit the findings.\",\"PeriodicalId\":501276,\"journal\":{\"name\":\"medRxiv - Public and Global Health\",\"volume\":\"35 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Public and Global Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.08.28.24312702\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Public and Global Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.08.28.24312702","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:最近的文献对 COVID-19 和流感住院儿童的发病率和死亡率给出了不同的结果,而基于人群的大型研究结果却很少。方法:我们提供了2020年和2021年因COVID-19或2016年至2021年因流感住院的18岁以下儿童的个人数据,以及来自奥地利健康保险基金的年龄、性别和地区匹配对照组的数据。主要结果是出院时间。次要结果为院内死亡、全因死亡率和因任何原因再次入院。COVID-19 组的中位随访时间为 430 天(IQR:245-552),流感组的中位随访时间为 1221 天(IQR:881-1599)。结果:研究期间,1063 名儿童因 COVID-19 住院,2781 名儿童因流感住院。与普通人群相比,因COVID-19或流行性感冒住院的儿童的疾病负担更重。据观察,与 COVID-19 患者相比,流感住院患者的年龄普遍较小,且使用多种药物的比例较高。各组别之间的出院时间无明显差异(HR:1.22 [95%-CI:0.97-1.55],p=0.093)。流感患者再次入院的风险明显更高(HR:1.23 [95%-CI:1.03-1.47],P=0.021)。COVID-19患者的院内死亡率(0.94% vs. 0.22%,p=0.004)和长期死亡率(p=0.009)明显高于COVID-19患者。据估计,COVID组住院后一年的死亡率为1.13%(CI:0.49-1.77),流感组为0.32%(CI:0.11-0.53)。结论:与流行性感冒相比,COVID-19 的病情较轻,但这并不意味着COVID-19 的病情较轻。两组患者的出院时间无明显差异,但流感组患者的再入院风险明显更高。COVID-19住院儿童的死亡率似乎较高,但严重事件的数量较少可能会限制研究结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Short- and Long-term Outcomes of children hospitalized with COVID-19 or Influenza: results of the AUTCOV study
Background: Recent literature gives different results on morbidity and mortality after COVID-19 as compared to Influenza hospitalized children and results of large, population based studies are scant. In this population-based study in Austria, we evaluated and compared the short- and long-term outcomes after COVID-19 or Influenza hospitalization and associations with their baseline drug profile. Methods: Individual data were provided on children ≤ 18 years hospitalized with COVID-19 in the years 2020 and 2021 or Influenza in 2016 to 2021 as well as on age-, sex- and region-matched controls from the Austrian Health Insurance Funds. The primary outcome was time to hospital discharge. Secondary outcomes were in-hospital death, all-cause mortality and readmission to hospital due to any reason. The median follow-up time was 430 days (IQR: 245-552) in the COVID-19 and 1221 days (IQR: 881-1599) in the Influenza group. Results: 1063 children were hospitalized due to COVID-19 and 2781 children due to Influenza in the study period. Children hospitalized due to COVID-19 or Influenza were more likely to have a larger disease burden as compared to the general population. Influenza hospitalized patients were observed to be generally younger and a larger percentage of polypharmacy than those with COVID-19. No significant difference in the time to hospital discharge was found between cohorts (HR: 1.22 [95%-CI: 0.97-1.55], p=0.093). The risk for readmission was significantly higher for Influenza (HR: 1.23 [95%-CI: 1.03-1.47], p=0.021). In-hospital mortality (0.94% vs. 0.22%, p=0.004) and long-term mortality (p=0.009) was significantly larger in COVID-19 patients. One-year mortality after hospitalization was estimated with 1.13% (CI: 0.49-1.77) in the COVID and 0.32% (CI: 0.11-0.53) in the Influenza group. Conclusion: A general picture of COVID-19 being a milder disease compared to Influenza may not be drawn. No significant difference for time to hospital discharge was observed between cohorts but the risk of readmission was significantly larger in the Influenza group. Death rates of COVID-19 hospitalized children seem to be higher, however, the low number of severe events may limit the findings.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信